Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Evofem-Biosciences"

2 News Found

USFDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences
Drug Approval | February 10, 2022

USFDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences

Adds five years of market exclusivity on approval


Lupin divests US commercial women's health specialty business to Evofem
News | July 17, 2024

Lupin divests US commercial women's health specialty business to Evofem

Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones